NanoBase™ Rx: The Pharmacy Compounding Industry's Full Replacement for HLB Chemistry
NanoBase™ Rx is the first pharmacy compounding excipient to combine a tri-domain nano-delivery architecture with a lyotropic liquid crystal matrix. Engineered at Pensive Beauty Labs. The three engineered nano-domains (lipophilic, hydrophilic, interfacial bridging) are organized within a biomimetic lamellar and bicontinuous cubic liquid crystal phase structure that matches the native liquid crystalline lamellar organization of stratum corneum intercellular lipids. No other US compounding excipient productizes this combination. Excipient only. No API supplied.
Why Most Skincare Actives Never Reach the Dermis
Conventional emulsions produce 1–100 µm carriers against a stratum corneum barrier with 10–50 nm intercellular spacing — a dimensional mismatch that precludes transepidermal transport. NanoBase™ tri-domain nano-delivery (125–195 nm, PDI ≤0.20) resolves all three HLB barriers simultaneously.

